Product Code: PM4857
The global Iliac stent market size is expected to reach USD 1,708.54 Million by 2032, according to a new study by Polaris Market Research. The report "Iliac Stent Market Share, Size, Trends, Industry Analysis Report, By Type (Self-expandable Stents, Balloon-expandable Stents, Others); By Artery lesions; By End-use, By Region, And Segment Forecasts, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Several stents are used during iliac stent surgeries for the treatment of iliac arterial lesions and aneurysms. According to studies, stents such as the EPIC stent have shown superior clinical outcomes than others when it comes to managing iliac arterial lesions. The self-expanding EPIC stent is a promising alternative for iliac artery procedures due to its flexibility, improved healing, and decreased neointimal hyperplasia.
As per the data published by the American Heart Association (AHA), around 8.5 Mn adults in the U.S. are suffering from Peripheral Arterial Disease (PAD). PAD blocks iliac arteries; therefore, iliac stenting is required for smoother heart functioning.
In addition, iliac artery aneurysms are treated using percutaneous stent-graft implantation, which offers a replacement for open surgery graft insertion. Stent grafts are implanted during this minimally invasive treatment to treat iliac aneurysms, providing a less invasive method than conventional surgical reconstruction.
In the common iliac artery, the DISCOVER research has clarified the differences among covered and uncovered balloon-expandable stents, highlighting the potential of PTFE-covered stents to lower restenosis rates and enhance clinical outcomes following endovascular therapy. Further supporting the benefits of primary stent implantation above balloon angioplasty for full iliac artery occlusions are the results of the STAG study, which show that stent intervention is associated with a higher rate of technical success and a lower rate of significant procedural problems.
For instance, in May 2022, to assess the safety & effectiveness of iCover for treating aorto-iliac athero-sclerotic lesions in patients with the arteriopathy in the lower limbs, the iliCo study, supervised by iVascular, started its first trial with the drug.
Iliac Stent Market Report Highlights
Self-expandable stents segment dominated the market owing to various studies demonstrated self-expanding stents are commonly used for iliac artery occlusions.
Balloon-expandable stents segment expected to grow at the fastest rate, due to its capabilities such as severe radial outward force, and ability to accurately place stents.
Complete obstructive lesion segment expected to grow at the fastest rate due to rising the incidence of PAD, advancements in medicine, and cardiovascular diseases.
North America dominated the iliac stents market due to the rising incidence of PAD and rising older population and increasing risk factors such as diabetic and obesity
The key market players include Abbott, BD, Biotronik SE & Co KG, Boston Scientific Corporation, Cook, Getinge AB, iVascular, Medtronic, and Terumo Corporation.
Polaris Market Research has segmented the Iliac Stent market report based on type, artery lesions, end use, and region:
Iliac Stent, Type Outlook (Revenue - USD Million, 2019 - 2032)
- Self-expandable Stents
- Balloon-expandable Stents
- Others
Iliac Stent, Artery Lesions Outlook (Revenue - USD Million, 2019 - 2032)
- Common Iliac Artery Lesions
- Severe Calcified Lesions
- Complete Obstructive Lesions
Iliac Stent, End Use Outlook (Revenue - USD Million, 2019 - 2032)
- Hospitals
- Ambulatory surgical centers
- Others
Iliac Stent, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Iliac Stent Market Insights
- 4.1. Iliac Stent Market - End-Use Snapshot
- 4.2. Iliac Stent Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Technological advancements in iliac stent designs
- 4.2.1.2. Increasing prevalence of peripheral artery disease (PAD)
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Limited awareness and underdiagnosis
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Iliac Stent Market End-Use Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Iliac Stent Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 5.3. Self-expandable Stents
- 5.3.1. Global Iliac Stent Market, by Self-expandable Stents, by Region, 2019-2032 (USD Million)
- 5.4. Balloon-expandable Stents
- 5.4.1. Global Iliac Stent Market, by Balloon-expandable Stents, by Region, 2019-2032 (USD Million)
- 5.5. Others
- 5.5.1. Global Iliac Stent Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Iliac Stent Market, by Artery Lesions
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 6.3. Common Iliac Artery Lesions
- 6.3.1. Global Iliac Stent Market, by Common Iliac Artery Lesions, by Region, 2019-2032 (USD Million)
- 6.4. Severe Calcified Lesions
- 6.4.1. Global Iliac Stent Market, by Severe Calcified Lesions, by Region, 2019-2032 (USD Million)
- 6.5. Complete Obstructive Lesions
- 6.5.1. Global Iliac Stent Market, by Complete Obstructive Lesions, by Region, 2019-2032 (USD Million)
7. Global Iliac Stent Market, by End-Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 7.3. Hospitals
- 7.3.1. Global Iliac Stent Market, by Hospitals, By Region, 2019-2032 (USD Million)
- 7.4. Ambulatory surgical centers
- 7.4.1. Global Iliac Stent Market, by Ambulatory surgical centers, By Region, 2019-2032 (USD Million)
- 7.5. Others
- 7.5.1. Global Iliac Stent Market, by Others, By Region, 2019-2032 (USD Million)
8. Global Iliac Stent Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Iliac Stent Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. Iliac Stent Market - North America
- 8.3.1. North America: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.3.2. North America: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.3.3. North America: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.3.4. Iliac Stent Market - U.S.
- 8.3.4.1. U.S.: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.3.5. Iliac Stent Market - Canada
- 8.3.5.1. Canada: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.3.5.3. Canada: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.4. Iliac Stent Market - Europe
- 8.4.1. Europe: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.4.2. Europe.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.4.3. Europe: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.4.4. Iliac Stent Market - UK
- 8.4.4.1. UK: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.4.4.2. UK.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.4.4.3. UK: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.4.5. Iliac Stent Market - France
- 8.4.5.1. France: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.4.5.2. France.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.4.5.3. France: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.4.6. Iliac Stent Market - Germany
- 8.4.6.1. Germany: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.4.6.3. Germany: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.4.7. Iliac Stent Market - Italy
- 8.4.7.1. Italy: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.4.7.3. Italy: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.4.8. Iliac Stent Market - Spain
- 8.4.8.1. Spain: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.4.8.3. Spain: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.4.9. Iliac Stent Market - Netherlands
- 8.4.9.1. Netherlands: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.4.10. Iliac Stent Market - Russia
- 8.4.10.1. Russia: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.4.10.3. Russia: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.5. Iliac Stent Market - Asia Pacific
- 8.5.1. Asia Pacific: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.5.4. Iliac Stent Market - China
- 8.5.4.1. China: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.5.4.2. China.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.5.4.3. China: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.5.5. Iliac Stent Market - India
- 8.5.5.1. India: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.5.5.2. India.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.5.5.3. India: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.5.6. Iliac Stent Market - Malaysia
- 8.5.6.1. Malaysia: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.5.7. Iliac Stent Market - Japan
- 8.5.7.1. Japan: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.5.7.3. Japan: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.5.8. Iliac Stent Market - Indonesia
- 8.5.8.1. Indonesia: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.5.9. Iliac Stent Market - South Korea
- 8.5.9.1. South Korea: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.6. Iliac Stent Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.6.4. Iliac Stent Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.6.5. Iliac Stent Market - UAE
- 8.6.5.1. UAE: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.6.5.3. UAE: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.6.6. Iliac Stent Market - Israel
- 8.6.6.1. Israel: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.6.6.3. Israel: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.6.7. Iliac Stent Market - South Africa
- 8.6.7.1. South Africa: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.7. Iliac Stent Market - Latin America
- 8.7.1. Latin America: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.7.3. Latin America: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.7.4. Iliac Stent Market - Mexico
- 8.7.4.1. Mexico: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.7.5. Iliac Stent Market - Brazil
- 8.7.5.1. Brazil: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.7.6. Iliac Stent Market - Argentina
- 8.7.6.1. Argentina: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abbott
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. BD
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Biotronik SE & Co KG
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Boston Scientific Corporation
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Cook
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Getinge AB
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. iVascular
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Medtronic
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Terumo Corporation
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. W. L. Gore & Associates, Inc
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development